ReviewTherapeutic advances in hematology2025

Novel small-molecule therapies for myelodysplastic syndromes with IPSS-R ⩾3.5 in patients aged 60 or older: current landscape and challenges.

Kehao Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.